Effectiveness of Dual Versus Triple Inhaled Therapy in Chronic Obstructive Pulmonary Disease Patients: Results from a Quasi-Experimental Study, Multan

Objective: To compare the efficacy of dual inhaled therapy and triple inhaled therapy in chronic obstructivepulmonary disease patients.Study Design: Quasi-experimental study.Place and Duration of Study: This study was conducted at the Department of Medicine, Combined MilitaryHospital (CMH), Multan, Pakistan from 1st January 2023 to 31st December 2023.Methods: A total of 60 patients with chronic obstructive pulmonary disease were included in this study andallocated to 2 equal groups based on clinical criteria. In Group-D, patients were given dual inhaled inhalertherapy (Corticosteroid+ Long acting β-2 agonists) while patients in Group-T were given triple inhaled inhalertherapy (Corticosteroid+ Long acting β-2 agonists+ long-acting muscarinic antagonist) twice daily. The primaryoutcome was set as the percentage of patients achieving a reduced number of moderate-severe exacerbations,while the secondary outcomes included improved post-dose forced expiratory volume, number of patientsachieving improved chronic obstructive pulmonary disease assessment test score, and baseline dyspnea indexfocal score after 6 months of treatment.Results: The results of primary outcomes showed significantly better efficacy in Group-T compared to Group-D,as a considerably higher number of patients had reduced frequency of moderate-severe chronic obstructivepulmonary disease exacerbations after 6 months (86.66% vs 53.33%, P=0.035).There was also significant improvement in secondary outcomes, including post-dose forced expiratory volumein 1 second, patients who had improved assessment test scores, as well as baseline dyspnea index focal score inGroup-T compared to Group-D.Conclusion: Triple inhaled therapy is more effective than dual inhaled therapy for reducing moderate-to-severechronic obstructive pulmonary disease exacerbations. How to cite this: Batool S, Khan JA, Asmat F, Wajid H, Hashmi Z. Effectiveness of Dual Versus Triple Inhaled Therapy in Chronic Obstructive Pulmonary Disease Patients: Results from a Quasi-Experimental Study, Multan. Life and Science. 2025; 6(4): 430-436. doi: http://doi.org/10.37185/LnS.1.1.763

Authors

Institutions

Publication Details

Journal
Life and Science
Published
2025-10-08
DOI
https://doi.org/10.37185/lns.1.1.763
Primary Topic
Inhalation and Respiratory Drug Delivery
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Effectiveness of Dual Versus Triple Inhaled Therapy in Chronic Obstructive Pulmonary Disease Patients: Results from a Quasi-Experimental Study, Multan

Zubair A. Hashmi, Faryal Asmat, Sidra Batool, Javed Khan et al.
Life and Science
Inhalation and Respiratory Drug Delivery
article

Effectiveness of Dual Versus Triple Inhaled Therapy in Chronic Obstructive Pulmonary Disease Patients: Results from a Quasi-Experimental Study, Multan

Zubair A. Hashmi, Faryal Asmat, Sidra Batool, Javed Khan, Hamna Wajid
article en

Abstract

Objective: To compare the efficacy of dual inhaled therapy and triple inhaled therapy in chronic obstructivepulmonary disease patients.Study Design: Quasi-experimental study.Place and Duration of Study: This study was conducted at the Department of Medicine, Combined MilitaryHospital (CMH), Multan, Pakistan from 1st January 2023 to 31st December 2023.Methods: A total of 60 patients with chronic obstructive pulmonary disease were included in this study andallocated to 2 equal groups based on clinical criteria. In Group-D, patients were given dual inhaled inhalertherapy (Corticosteroid+ Long acting β-2 agonists) while patients in Group-T were given triple inhaled inhalertherapy (Corticosteroid+ Long acting β-2 agonists+ long-acting muscarinic antagonist) twice daily. The primaryoutcome was set as the percentage of patients achieving a reduced number of moderate-severe exacerbations,while the secondary outcomes included improved post-dose forced expiratory volume, number of patientsachieving improved chronic obstructive pulmonary disease assessment test score, and baseline dyspnea indexfocal score after 6 months of treatment.Results: The results of primary outcomes showed significantly better efficacy in Group-T compared to Group-D,as a considerably higher number of patients had reduced frequency of moderate-severe chronic obstructivepulmonary disease exacerbations after 6 months (86.66% vs 53.33%, P=0.035).There was also significant improvement in secondary outcomes, including post-dose forced expiratory volumein 1 second, patients who had improved assessment test scores, as well as baseline dyspnea index focal score inGroup-T compared to Group-D.Conclusion: Triple inhaled therapy is more effective than dual inhaled therapy for reducing moderate-to-severechronic obstructive pulmonary disease exacerbations. How to cite this: Batool S, Khan JA, Asmat F, Wajid H, Hashmi Z. Effectiveness of Dual Versus Triple Inhaled Therapy in Chronic Obstructive Pulmonary Disease Patients: Results from a Quasi-Experimental Study, Multan. Life and Science. 2025; 6(4): 430-436. doi: http://doi.org/10.37185/LnS.1.1.763

Life and ScienceVol. 6(4)
Foundation University Islamabad (PK), Combined Military Hospital (PK)
Openalex Percentile: Top 50%
Inhalation and Respiratory Drug Delivery
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.